Skip to main content
logo
IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
559.07
+0.27 (0.05%)
Jul 31, 2026, 4:00 PM EDT - Market closed

IDEXX Laboratories Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,4464,3043,8983,6613,3673,215
Revenue Growth
13.08%10.42%6.46%8.72%4.73%18.80%
Gross Profit
2,7592,6602,3792,1902,0041,889
Operating Income
1,4061,3601,1281,097898.77932.03
Net Income
1,0951,059887.87845.04679.09744.85
Earnings Per Share
13.5813.0810.6710.068.038.60
EPS Growth
25.51%22.59%6.06%25.28%-6.63%28.17%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
IDEXX VetLab Consumables
1,5651,4971,3031,1881,0571,007
Rapid Assay Products
349.85348.95359.75344.49313.67296.85
Reference Laboratory Diagnostic & Consulting
1,4661,4241,3361,2791,1781,124
CAG Diagnostics Services & Accessories
140.99137.42130.37124.05111.26107.27
CAG Diagnostics Capital - Instruments
210.66200.21131.93137.6147.33149.14
Veterinary Software, Services & Diagnostics
355.6345.88312.62279.33251.19206.26
Water Segment
206.09201.15185.11168.15155.72146.51
LPD Segment
135.67131.79122.06121.66122.61135.89
Other
16.8317.4816.2918.7930.243.01
Revenue (Total)
4,4464,3043,8983,6613,3673,215

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
200.53180.07288.27453.93112.55144.45
Total Debt
1,079948.99965.411,0481,4501,011
Net Cash (Debt)
-878.07-768.92-677.14-593.62-1,337-866.62
Net Cash Growth
------
Net Cash Per Share
-10.90-9.49-8.13-7.07-15.80-10.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,2101,182929906.51542.98755.55
Capital Expenditures
-126.63-124.68-120.92-133.63-148.84-119.55
Free Cash Flow
1,0831,057808.08772.88394.15636
Free Cash Flow Growth
27.81%30.82%4.55%96.09%-38.03%17.54%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.05%61.80%61.04%59.82%59.52%58.76%
Operating Margin
31.63%31.60%28.95%29.97%26.69%28.99%
Pretax Margin
30.80%30.77%28.48%28.99%25.54%28.07%
Profit Margin
24.63%24.62%22.78%23.08%20.17%23.17%
FCF Margin
24.37%24.56%20.73%21.11%11.71%19.78%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
41.1351.7238.7555.1750.8076.57
Forward PE
37.0748.0335.3551.9344.2573.77
P/FCF Ratio
40.7051.0141.7559.6385.8087.55
PS Ratio
9.9212.538.6612.5910.0417.32